Humimic Biosystems has developed a comprehensive suite of five innovative organ-on-chip technologies protected by four strategic patents. Their portfolio includes the CoCo/NICE Chip for heart muscle contractility measurement with piezoelectric sensing, the AirLOC platform that uniquely combines nasal and lung airways, the versatile DynaMOC system that serves as the foundation for complex multilayered tissue modeling, the AV variant specifically optimized for heart valve research, and the MINT Chip for blood-brain barrier studies. This integrated ecosystem of human-relevant testing platforms addresses critical gaps in pharmaceutical drug development by providing earlier, more accurate data that could potentially save hundreds of millions in development costs by identifying ineffective compounds before expensive animal and human trials, ultimately bringing life-saving medications to market faster and more affordably.
Innovative nasal model that uniquely combines upper and lower respiratory systems with two-way airflow simulation.
Heart muscle-on-chip platform with piezoelectric sensing that non-invasively measures cardiac cell contractility, enabling drug screening, disease modeling, and personalized treatment testing.
Enhanced contractility evaluation platform using PE-PDMS material to measure force generated by heart muscle cells, particularly useful for studying ethnic differences in cardiac function.
Multi-layered, multi-chamber platform that simulates complex tissue environments with different flow profiles and mechanical strains, replicates the three-layered structure of aortic valves with appropriate fluid flows, designed specifically for heart valve disease research.
Innovative nasal model that uniquely combines upper and lower respiratory systems with two-way airflow simulation.
Our Partners
